Lactobacillus Farciminis and Hyperalgesia

Phase 1

Completed

• Conditions: Inflammation; Pain
• Interventions: Drug: Lactobacillus farciminis; Drug: Placebo

• Registration Number: NCT00852865
• Lead Sponsor: Lallemand SAS

Brief Summary

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-02
• Study First Submitted: 2009-02-25
• Study First Submitted QC: 2009-02-26
• Study First Posted: 2009-02-27
• Status Verified: 2009-04
• Primary Completion: 2009-04
• Study Completion: 2009-04
• Last Update Submitted: 2009-04-30
• Last Update Posted: 2009-05-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• healthy volunteers

Exclusion Criteria

• consumption of yogurts

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Lactobacillus farciminis	24 healthy volunteers consuming L.farciminis during three weeks
2	Placebo	24 healthy volunteers consuming placebo during three weeks

Primary Outcome Measures

Name	Time	Method
Measurement of the mchanical pain threshold in primary and secondary areas by using a punctate stimulus.

Secondary Outcome Measures

Name	Time	Method
Measurement of cutaneous temperature of hyperalgesia areas

Trial Locations

Locations (1)

Cpc / Cic-Inserm 501; 🇫🇷 Clermont-Ferrand, France